Pseudoexon activation in the DMD gene as a novel mechanism for becker muscular dystrophy

Human Mutation

Volumn 21, Issue 6, 2003, Pages 608-614

  Tuffery Giraud, Sylvie ^a   Saquet, Céline ^a   Chambert, Sylvie ^a   Claustres, Mireille ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Becker muscular dystrophy; DMD; Duchenne muscular dystrophy; Dystrophin; Pseudoexon; Splicing; Transcript analysis

Indexed keywords

COMPLEMENTARY DNA; CREATINE KINASE; DYSTROPHIN;

ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CASE REPORT; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE ACTIVATION; GENE MUTATION; GENETIC TRANSCRIPTION; GENOME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INTRON; MALE; MENTAL DEFICIENCY; MUSCULAR DYSTROPHY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SKELETAL MUSCLE;

ADULT; ALTERNATIVE SPLICING; BASE SEQUENCE; DYSTROPHIN; EXONS; GENOTYPE; HUMANS; INTRONS; MENTAL RETARDATION; MOLECULAR SEQUENCE DATA; MUSCLES; MUSCULAR DYSTROPHY, DUCHENNE; MUTAGENESIS, INSERTIONAL; PHENOTYPE; PROTEIN ISOFORMS; RNA SPLICE SITES; RNA, MESSENGER;

INSERTION SEQUENCES;

EID: 0038657626     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10214     Document Type: Article

References (23)

1. Angelini C, Fanin M, Freda MP, Martinello F, Miorin M, Malacini P, Siciliano G, Pegoraro E, Rosa M, Danieli GA. 1996. Prognostic factors in mild dystrophinopathies. J Neurol Sci 142:70-78.
2. Beggs AH, Hoffman EP, Snyder JR, Arahata K, Specht L, Shapiro F, Angelini C, Sugita H, Kunkel LM. 1991. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet 49:54-67.
3. Bushby KM, Gardner-Medwin D, Nicholson LV, Johnson MA, Haggerty ID, Cleghorn NJ, Harris JB, Bhattacharya SS. 1993. The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy II. Correlation of phenotype with genetic and protein abnormalities. J Neurol 240:105-112.
4. Chillon M, Dork T, Casals T, Gimenez J, Fonknechten N, Will K, Ramos D, Nunes V, Estivill X. 1995. A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811+1.6kbA>G, produces a new exon, high frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype. Am J Hum Genet 56:623-629.
5. Curtis A, Haggerty D. 2001. Deletion and dublication analysis in males affected with Duchenne or Becker muscular dystrophy. In: Bushby KMD, Anderson LVB, editors. Methods in molecular medicine, vol 43: Muscular dystrophy: methods and protocols. Totowa, NJ: Humana Press, Inc. 5:53-84.
6. De Klein A, Riegman PH, Bijlsma EK, Heldoom A, Muijtjens M, den Bakker MA, Avezaat CJ, Zwarthoff EC. 1998. A G>A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2. Hum Mol Genet 7:393-398.
7. Dunham I, Shimizu N, Roe BA, Chissoe S, Hunt AR, Collins JE, Bruskiewich R, Beare DM, Clamp M, Smink LJ, Ainscough R, Almeida JP, Babbage A, Bagguley C, Bailey J, Barlow K, Bates KN, Beasley O, Bird CP, Blakey S, Bridgeman AM, Buck D, Burgess J, Burrill WD, O'Brien KP, et al. 1999. The DNA sequence of human chromosome 22. Nature 402:489-495.
8. Felisari G, Martinelli Boneschi F, Bardoni A, Sironi M, Comi GP, Robotti M, Turconi AC, Lai M, Corrao G, Bresolin N. 2000. Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology 2000 55:559-564.
9. Hoffman EP, Kunkel LM. 1988. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron 2:1019-1029.
10. Ikezawa M, Nishino I, Goto Y, Miike T, Nonaka I. 1998. Newly recognized exons induced by a splicing abnormality from an intronic mutation of the dystrophin gene resulting in Duchenne muscular dystrophy. Mutation in Brief No. 213. Online. Hum Mutat 13:170.
11. Krawczak M, Reiss J, Cooper DN. 1992. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-54.
12. Mehler ME 2000. Brain dystrophin, neurogenetics and mental retardation. Brain Res Rev 32:277-307.
13. Metherell LA, Akker SA, Munroe PB, Rose SJ, Caulfield M, Savage MO, Chew SL, Clark AJL. 2001. Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity. Am J Hum Genet 69:641-646.
14. Moizard MP, Billard C, Toutain A, Berret F, Marmin N, Moraine C. 1998. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? Am J Med Genet 80:32-41.
15. Monaco AP, Bertelson CJ, Liechti-Galliti S, Moser H, Kunkel LM. 1988. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2:90-95.
16. Pagani F, Buratti E, Stuani C, Bendix R, Dork T, Baralle FE. 2002. A new type of mutation causes a splicing defect in ATM. Nat Genet 30:426-429.
17. Shapiro MB, Senapathy P. 1987. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res 15:7155-7174.
18. Smith TA, Yau SC, Bobrow M, Abbs SA. 1999. Identification and quantification of somatic mosaicism for a point mutation in a Duchenne muscular dystrophy family. J Med Genet 36:313-315.
19. Sun H, Chasin LA. 2000. Multiple splicing defects in an intronic false exon. Mol Cell Biol 20:6414-6425.
20. Tuffery-Giraud S, Chambert S, Demaille J, Claustres M. 1999. Point mutations in the dystrophin gene: evidence for frequent use of cryptic splice sites as a result of splicing defects. Hum Mutat:359-368.
21. van Essen AJ, Abbs S, Baiget M, Bakker E, Boileau C, van Broeckhoven C, Bushby K, Clarke A, Claustres M, Covone AE, et al. 1992. Parental origin and germline mosaicism of deletions and duplications of the dystrophin gene: a European study. Hum Genet 88:249-257.
22. Vervoort R, Gitzelmann R, Lissens W, Liebaers I. 1998. A mutation (IVS8+0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an Alu-element intron 8 of the B-glucuronidase gene. Hum Genet 103:686-693.
23. Wang M, Dotzlaw H, Fuqua SA, Murphy LC. 1997. A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion. Breast Cancer Treat 44:145-151.